CARY, N.C., Dec. 12, 2022 (GLOBE NEWSWIRE) — According to the National Cancer Institute, roughly 1.9 million people will be diagnosed with cancer in the United States in 2022. Stirling CBD founder Joe Kryszak’s life changed when he received a cancer diagnosis in 2020. Kryszak shares how his company, Stirling CBD, helped him discover his cancer and contribute to his treatment and …
New York, NY: The adoption of statewide medical cannabis access laws is associated with lower rates of opioid use and with a reduction in the number of pain-related hospitalizations among newly diagnosed patients with cancer, according to data published in the journal JAMA Oncology. Investigators affiliated with Cornell University’s Weill Medical College assessed the relationship between medical cannabis legalization and opioid-related and pain-related outcomes …
Melbourne, Australia: Children with autism spectrum disorder (ASD) show significant improvements in their symptoms following the use of plant-derived CBD dominant extracts, according to phase 1 trial results reported by Australian media. Patients in the trial consumed extracts containing CBD and other non-THC phyto-cannabinoids twice daily for a period of at least two months. Researchers affiliated with the study said that patients experienced …
San Antonio, TX: Medical cannabis retail access is inversely associated with drug overdose mortality rates, according to the findings of a literature review published in the journal Drug and Alcohol Dependence. Investigators affiliated with the University of Texas and Arizona State University reviewed data from over 50 studies highlighting county-level predictors of overdose mortality. “[M]easures related to cannabis dispensaries, substance use treatment, social capital, and proportions of family …
Chicago, IL: The administration of a proprietary transdermal CBD gel (aka ZYN002) is safe and effective in patients with Fragile X syndrome (FXS), according to phase 3 clinical trial data published in the Journal of Neurodevelopmental Disorders. FXS is a genetic disorder resulting in developmental delays, learning disabilities, and behavioral problems, such as aggression and attention deficits. Over 200 pediatric patients (mean age 9.7 years) participated in …
EDMONTON, AB, Dec. 9, 2022 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is excited to announce its Greybeard Cannabis Co. brand has won KIND Magazine’s ‘Best Diamonds of the Year’ award, as voted by hundreds of budtenders, store managers and independent cannabis retail owners across Canada. Greybeard is known for …
TALLAHASSEE, Fla., Dec. 9, 2022 /PRNewswire/ — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the official launch of Khalifa Kush premium medical marijuana products statewide in all Trulieve branded Maryland retail locations. This statewide exclusive partnership with multi-platinum selling, GRAMMY® and Golden Globe® Award-nominated recording artist Wiz Khalifa begins on Saturday, December 10. Trulieve will …
NEW YORK (PRWEB) DECEMBER 08, 2022 The Bluntness, one of the fastest growing digital media and marketing platforms covering the intersection of cannabis & psychedelic culture, commerce and community, today announced the launch of a new community platform, Bluntness Kitchen. Through the platform, the global cannabis community can now obtain members-only access to Chef-driven “kitchens” to learn from the best, and mix …
SACRAMENTO, Calif.–(BUSINESS WIRE)–The CA State Fair today announced the second annual, state-agency sanctioned cannabis competition is set to take place in conjunction with the 2023 CA State Fair. Following the first year’s success, cannabis will once again be celebrated alongside California’s rich agricultural industries on the official state fair roster including wine, craft beer, olive oil and cheese. The CA State Fair …
BARRIE, ON, Dec. 8, 2022 /PRNewswire/ – MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce the recognition of CBD brand of the year from Kind Magazine, as voted by front line retail staff across Canada. “MediPharm Labs is honoured to be selected as CBD Brand of the Year …